LD-2 disclosure · 1st Quarter - Report
CELGENE CORPORATION
Client
- Location
- New Jersey · United States of America
Registrant
- Description
- 8/1/2004
- Location
- Summit, New Jersey, United States of America
Lobbying activities
2 issuesCopyright/Patent/Trademark
Issues relating to Patent Reform.
LobbyistsALANNA TEMME
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
HR 985, FAST Generics Act, provisions regarding REMS. H.R. 1730, Cancer Drug Parity Act, regarding all provisions. S. 741, Cancer Drug Parity Act,regarding all provisions. H.R. 2279, Safe Step Act, issues relating to Step Therapy / Fail First. HR 965 / S. 340, CREATES Act, provisions regarding REMS. Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies. Issues relating to Medicare Reimbursement and Medicare Part D / Part B.
LobbyistsPATRICK GLIHA · MATTHEW SCHUMAKER · GREG CHESMORE · STEPHEN RUBRIGHT · ALANNA TEMME · HELEN FITZPATRICK
TargetedSENATE · HOUSE OF REPRESENTATIVES